Preliminary results in invasive bladder cancer with transurethral resection, neoadjuvant chemotherapy and combined pelvic irradiation plus cisplatin chemotherapy

The Journal of Urology
G R ProutH H Young

Abstract

Preliminary data are presented of a clinically feasible pilot study to select a significant subgroup of patients among those with muscle-invading bladder tumors for local cure and bladder preservation, while also to offer all patients the possibility of preventing the development of distant metastases. Transurethral debulking surgical resection was combined with neoadjuvant methotrexate, cisplatin and vinblastine chemotherapy plus 2 additional courses of cisplatin and 4,000 cGy. If tumor was found on cystoscopic re-evaluation by biopsy and for cytology after cisplatin and partial irradiation (4,000 cGy.) immediate cystectomy was advised. If tumor was not found consolidation by a radiotherapy boost to a total of 6,480 cGy. plus 1 additional course of cisplatin was given. Of 53 consecutive patients the planned treatment was completed in 42 (79%). With a median followup of 26 months (range 15 to 42 months), 72% of all entered patients were alive, 70% have not required cystectomy and 74% have not had distant metastases. Among the 42 patients who completed the planned protocol chemotherapy dose reductions were required in 39% for stomatitis, bone marrow depression and/or renal dysfunction. There were 2 serious complications but no t...Continue Reading

References

Feb 1, 1977·Cancer·E A SotoA J Tiltman
Jun 1, 1979·Cancer·G R ProutW U Shipley
Oct 1, 1975·Radiology·D R GoffinetM A Bagshaw
Feb 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L EapenL Gerig
Oct 1, 1988·International Journal of Radiation Oncology, Biology, Physics·R SauerC Bornhof
Mar 1, 1984·The Journal of Urology·J E MontieB H Stewart
May 1, 1980·The Journal of Urology·N H Slack, G R Prout
Feb 1, 1980·British Journal of Urology·W F Whitmore

❮ Previous
Next ❯

Citations

May 1, 1993·The Journal of Urology·J B Thrasher, E D Crawford
Nov 4, 2006·World Journal of Urology·Jason A EfstathiouWilliam U Shipley
Mar 5, 2016·Current Treatment Options in Oncology·Omar M S El-TajiSyed A Hussain
Jun 1, 1995·International Journal of Urology : Official Journal of the Japanese Urological Association·K KoisoH van Poppel
Nov 28, 2008·BJU International·Raymond H MakWilliam U Shipley
Dec 4, 2009·Expert Review of Anticancer Therapy·Faysal A YafiWassim Kassouf
Sep 1, 1992·Seminars in Surgical Oncology·H I Scher, L Norton
Jan 1, 1994·Cancer Chemotherapy and Pharmacology·J E Pontes
Jun 1, 1995·International Journal of Urology : Official Journal of the Japanese Urological Association·C N SternbergT A Splinter
Sep 1, 1997·Seminars in Surgical Oncology·W A See, C J Berman
Nov 4, 1993·The New England Journal of Medicine·D S KaufmanJ T Efird
Nov 15, 2011·International Journal of Urology : Official Journal of the Japanese Urological Association·Haruhito AzumaTakanobu Ubai
May 30, 2013·American Society of Clinical Oncology Educational Book·Nicholas D James, Syed A Hussain
Nov 4, 1993·The New England Journal of Medicine·H I Scher
Nov 30, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·L Sengeløv, H von der Maase
Dec 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M A KuczykU Jonas
Jul 1, 1998·Urologic Oncology·H TsujiiJ Shimazaki
Feb 1, 1994·Critical Reviews in Oncology/hematology·G J BoslH I Scher
Apr 2, 1993·International Journal of Radiation Oncology, Biology, Physics·W TesterE Hammond

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.